Xundou Li

700 total citations
27 papers, 420 citations indexed

About

Xundou Li is a scholar working on Molecular Biology, Spectroscopy and Immunology. According to data from OpenAlex, Xundou Li has authored 27 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Spectroscopy and 6 papers in Immunology. Recurrent topics in Xundou Li's work include Metabolomics and Mass Spectrometry Studies (6 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Xundou Li is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (6 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Xundou Li collaborates with scholars based in China and United Kingdom. Xundou Li's co-authors include Xian‐Da Yang, Youhe Gao, Jinhong Duan, Mindi Zhao, Menglin Li, Chen Shao, Jianqiang Wu, Lulu Jia, Zhaoyi Li and Fanshuang Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Xundou Li

25 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xundou Li China 13 244 86 68 63 56 27 420
Asfa Alli‐Shaik Singapore 10 153 0.6× 36 0.4× 23 0.3× 23 0.4× 29 0.5× 16 332
Alok K. Shah Australia 12 204 0.8× 61 0.7× 27 0.4× 8 0.1× 41 0.7× 27 330
Zijun Wang China 12 169 0.7× 25 0.3× 152 2.2× 51 0.8× 34 0.6× 25 392
Go Urabe United States 14 355 1.5× 99 1.2× 23 0.3× 30 0.5× 47 0.8× 29 558
Christelle Machon France 14 238 1.0× 29 0.3× 29 0.4× 13 0.2× 98 1.8× 44 526
Yueyao Wang China 13 403 1.7× 20 0.2× 44 0.6× 11 0.2× 43 0.8× 25 529
Simon J. Henderson United Kingdom 8 240 1.0× 20 0.2× 40 0.6× 36 0.6× 87 1.6× 13 545
Xiaoping Ao United States 11 150 0.6× 51 0.6× 70 1.0× 6 0.1× 61 1.1× 13 482
Kavin G. Shah United States 10 132 0.5× 33 0.4× 22 0.3× 10 0.2× 24 0.4× 17 488
Olga Will Germany 11 138 0.6× 18 0.2× 44 0.6× 43 0.7× 87 1.6× 27 352

Countries citing papers authored by Xundou Li

Since Specialization
Citations

This map shows the geographic impact of Xundou Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xundou Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xundou Li more than expected).

Fields of papers citing papers by Xundou Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xundou Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xundou Li. The network helps show where Xundou Li may publish in the future.

Co-authorship network of co-authors of Xundou Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xundou Li. A scholar is included among the top collaborators of Xundou Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xundou Li. Xundou Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xundou, et al.. (2026). Targeted drug delivery to AML by OFA/iLRP aptamer guided DNA nanostructure. Scientific Reports. 16(1). 4377–4377.
2.
Li, Xundou, et al.. (2024). Novel nanotherapeutics for cancer immunotherapy by albumin nanoparticles functionalized with PD-1 and PD-L1 aptamers. Cancer Nanotechnology. 15(1). 9 indexed citations
3.
4.
Li, Xundou, et al.. (2023). Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine. Journal of Cancer Research and Clinical Oncology. 149(10). 7515–7527. 9 indexed citations
5.
Li, Xundou, et al.. (2023). Novel bispecific aptamer targeting PD-1 and nucleolin for cancer immunotherapy. Cancer Nanotechnology. 14(1). 11 indexed citations
6.
Li, Xundou, et al.. (2020). <p>Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel</p>. International Journal of Nanomedicine. Volume 15. 6737–6748. 57 indexed citations
7.
Li, Xundou, et al.. (2020). <p>Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin</p>. International Journal of Nanomedicine. Volume 15. 2119–2129. 32 indexed citations
8.
Hu, Yan, et al.. (2019). Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells. Scientific Reports. 9(1). 7343–7343. 14 indexed citations
9.
Zhang, Fanshuang, et al.. (2019). Preliminary study of the urinary proteome in Li and Han ethnic individuals from Hainan. Science China Life Sciences. 63(1). 125–137. 3 indexed citations
10.
Hu, Yan, et al.. (2019). Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting. Molecules. 24(3). 478–478. 22 indexed citations
11.
Zhao, Mindi, Jianqiang Wu, Xundou Li, & Youhe Gao. (2018). Urinary candidate biomarkers in an experimental autoimmune myocarditis rat model. Journal of Proteomics. 179. 71–79. 23 indexed citations
12.
Gao, Youhe, Xundou Li, Weiwei Deng, & Heng Wang. (2018). The identification of urinary biomarkers for malaria in mouse model. 7(2).
13.
Zhang, Fanshuang, et al.. (2018). Early Candidate Urine Biomarkers for Detecting Alzheimer’s Disease Before Amyloid-β Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model. Journal of Alzheimer s Disease. 66(2). 613–637. 29 indexed citations
14.
Li, Xundou & Youhe Gao. (2016). Potential urinary aging markers of 20-month-old rats. PeerJ. 4. e2058–e2058. 6 indexed citations
15.
Zhao, Mindi, Xundou Li, Menglin Li, & Youhe Gao. (2015). Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome. PeerJ. 3. e813–e813. 8 indexed citations
16.
Wang, Xiaorong, Xundou Li, Lulu Jia, & Youhe Gao. (2014). [Comparison of two urinary protein preparation methods: nitrocellulose membrane preservation and acetone precipitation].. PubMed. 30(6). 982–9. 1 indexed citations
17.
Zhao, Mindi, et al.. (2014). Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Science. 12(1). 42–42. 26 indexed citations
18.
Jia, Lulu, Xundou Li, Chen Shao, et al.. (2013). Using an Isolated Rat Kidney Model to Identify Kidney Origin Proteins in Urine. PLoS ONE. 8(6). e66911–e66911. 9 indexed citations
19.
Li, Xundou, et al.. (2013). Identification and characterization of cow's milk proteins from the rat intestinal lymph using a proteomic strategy. PROTEOMICS. 13(17). 2649–2656. 5 indexed citations
20.
Shao, Chen, Menglin Li, Xundou Li, et al.. (2011). A Tool for Biomarker Discovery in the Urinary Proteome: A Manually Curated Human and Animal Urine Protein Biomarker Database. Molecular & Cellular Proteomics. 10(11). M111.010975–M111.010975. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026